First Trust Advisors LP Amneal Pharmaceuticals, Inc. Transaction History
First Trust Advisors LP
- $108 Billion
- Q4 2024
A detailed history of First Trust Advisors LP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, First Trust Advisors LP holds 672,403 shares of AMRX stock, worth $4.79 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
672,403
Previous 612,802
9.73%
Holding current value
$4.79 Million
Previous $5.1 Million
4.45%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding AMRX
# of Institutions
209Shares Held
124MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$106 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$87.9 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$80.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$76.4 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$64 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.08B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...